On Friday, American Campus Communities, Inc. (NYSE:ACC)’s shares declined -0.43% to $39.54.
American Campus Communities, Inc. (ACC) declared that the company will report financial results for the second quarter 2015 after the market close on Monday, July 27, 2015. The company will host its quarterly earnings conference call for investors and other interested parties on Tuesday, July 28, 2015 at 11 a.m. Eastern Time (ET). ACC administration will talk about the quarterly results and business outlook for 2015 on the call. The press release will be accessible in the Investor Relations section of the company’s website.
American Campus Communities, Inc. is an independent equity real estate investment trust. The firm invests in the real estate markets of the United States. It primarily engages in developing, owning, and managing high-quality student housing communities. The firm diversifies its functions across acquisition, design, financing, development, construction administration, leasing and administration of student housing properties. American Campus Communities, Inc. was formed in 1993 and is based in Austin, Texas.
Western Asset Mortgage Capital Corp (NYSE:WMC)’s shares dropped -0.77% to $15.47.
Western Asset Mortgage Capital Corp (WMC) declared that its Board of Directors has declared a cash dividend of $0.64 per share for the second quarter of 2015. Recently dividend is payable on July 28, 2015 to common shareholders of record as of June 29, 2015, with an ex-dividend date of June 25, 2015.
The Company also declared its estimated book value per share, as of May 31, 2015 was about $14.87. The May 31, 2015 book value is unaudited and is only an estimate which has not been verified or reviewed by any third party and is subject to normal quarterly reconciliation and other procedures. Further, the estimated book value is as of May 31, 2015 and does not comprise the dividend declared recently. Book value will fluctuate with market conditions, the results of the Company’s operations and other factors. The Company’s current book value may be materially different from the May 31, 2015 estimated book value.
Western Asset Mortgage Capital Corporation operates as a real estate investment trust in the United States. It primarily focuses on investing in, financing, and managing agency and non-agency residential mortgage-backed securities and commercial mortgage-backed securities. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2009 and is based in Pasadena, California.
At the end of Friday’s trade, Caladrius Biosciences Inc (NASDAQ:CLBS)‘s shares surged 2.56% to $2.00.
Caladrius Biosciences Inc (CLBS) declared that it has reached a material transfer agreement with the University of Southern California and the California Institute of Technology, concerning next-generation strategies for its core cancer technology.
This research partnership will build on Caladrius’ highly successful manufacturing protocol for its lead cancer program, CLBS20 (aka NBS20), by exploring techniques to further enhance the isolation of cancer initiating cells with the aim of increasing the number of cancer patients that might benefit from treatment.
CLBS20 is the subject of a Phase 3 clinical trial investigating its efficacy in the treatment of late-stage melanoma, the Intus Study. The trial has been granted a Special Protocol Assessment by the US Food and Drug Administration (FDA) and the CLBS20 development program has been granted Orphan Drug and Fast Track designations by FDA. Randomization of the first patient in the Intus trial occurred in April 2015.
“This partnership illustrates Caladrius’ continued commitment to the optimization of our technologies through association with two prominent research universities,” said Dr. David J. Mazzo, Caladrius’ Chief Executive Officer.
Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, develops cell based therapeutics in the United States. It is developing NBS20, a targeted cancer immunotherapy product that is in Phase III clinical trials for the treatment of metastatic melanoma; NBS10, a ischemic repair product that is in Phase II clinical trial to preserve heart muscle function following an acute myocardial infarction; and NBS03D, an immune modulation product that is in Phase II clinical trials for the treatment of type 1 diabetes. The company, through its partner, Progenitor Cell Therapy, offers process development and clinical manufacturing services.
Charter Communications, Inc. (NASDAQ:CHTR), ended its Friday’s trading session with -0.46% loss, and closed at $169.67.
Charter Communications, Inc. (CHTR) released the following statement from President and CEO Tom Rutledge in response to the passing of Ralph Roberts.
Ralph was a true cable industry pioneer and Philadelphia gentleman. His contributions to the development and continued success of the cable industry are numerous, and his legacy will endure for generations to come. Our thoughts are with the Roberts family and the entire Comcast organization.
Charter Communications, Inc., through its auxiliaries, provides entertainment, information, and communications solutions to residential and commercial customers in the United States. The company offers cable video programming services, counting basic and digital video, premium channels, on-demand, pay-per-view, high definition television, and digital video recorder services, in addition to Charter TV App, which enables video customers to search and discover content on various devices, counting the iPhone, iPad, iPod Touch, and Android based tablets. It also provides Internet services, such as residential Internet services; Charter.net, an Internet portal that provides multiple e-mail addresses, in addition to various entertainment, games, news, and sports content; and Charter Security Suite, which protects computers from viruses and spyware, in addition to offers parental control features.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
